GNH USA

Europe — EMA

Menyeles (Salbutamol Sulfate, Ipratropium Bromide)

GNH USA supplies Menyeles (Salbutamol/Ipratropium), a bronchodilator for asthma and chronic obstructive pulmonary disease. Request a quote for global supply.

Salbutamol Sulfate, Ipratropium Bromide

Request sourcing

1
Pack/s

What is Salbutamol Sulfate, Ipratropium Bromide?

Salbutamol sulfate, the active ingredient in Menyeles, is a bronchodilator presented as a combination inhalation solution for inhalation use. It relaxes airway smooth muscle to improve breathing in patients with asthma and chronic obstructive pulmonary disease and helps reduce symptoms such as wheezing and shortness of breath.

GNH USA supplies Menyeles as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance, regulatory compliance and reliable global distribution and timely delivery to meet patient needs.

What is Salbutamol Sulfate, Ipratropium Bromide used for?

Menyeles, a combination bronchodilator, is used to manage obstructive airway diseases.

- Asthma: improves airflow and reduces acute bronchospasm. - Chronic obstructive pulmonary disease (COPD): alleviates bronchospasm and enhances lung function. - Acute bronchospasm: provides rapid relief of wheezing and shortness of breath.

What are the side effects of Salbutamol Sulfate, Ipratropium Bromide?

Menyeles may cause a range of adverse reactions.

Common Side Effects: - Tremor - Headache - Throat irritation - Cough

Serious or Rare Side Effects: - Paradoxical bronchospasm - Angioedema - Cardiac arrhythmia

What precautions apply to Salbutamol Sulfate, Ipratropium Bromide?

Before prescribing Menyeles, clinicians should consider several safety aspects.

- Assess respiratory status: confirm diagnosis and baseline lung function. - Monitor cardiovascular parameters: watch heart rate and blood pressure. - Use with caution in patients with known cardiovascular disease. - Avoid in individuals with documented hypersensitivity to salbutamol, ipratropium, or formulation excipients. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

What does Salbutamol Sulfate, Ipratropium Bromide interact with?

Menyeles can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Non‑selective β‑blockers: may diminish bronchodilator effect and precipitate bronchospasm. - Monoamine oxidase inhibitors (MAOIs): increase risk of cardiovascular stimulation. - Tricyclic antidepressants: may enhance tachycardia.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive bronchodilator effect may increase side‑effects. - Other inhaled β2‑agonists: risk of cumulative tachycardia. - Anticholinergic agents: may increase anticholinergic load. - Diuretics: monitor electrolyte balance and blood pressure.

Frequently asked questions

What is Menyeles used for?+
Menyeles is a prescription inhalation medication that combines salbutamol sulfate and ipratropium bromide. It is indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD), providing both rapid relief of bronchospasm and long‑term maintenance of airway patency.
How does salbutamol and ipratropium work in Menyeles?+
Salbutamol activates β2‑adrenergic receptors on airway smooth muscle, causing relaxation, while ipratropium blocks muscarinic M3 receptors, preventing acetylcholine‑induced constriction. The complementary mechanisms produce synergistic bronchodilation, improving airflow in obstructive lung conditions.
What is the usual dose of Menyeles?+
The dosage of Menyeles is individualized by the prescribing clinician based on disease severity, patient age, and response to therapy. The prescriber determines the number of inhalations per day and the timing, following local prescribing guidelines and product labeling.
Is Menyeles safe during pregnancy or breastfeeding?+
Safety data for Menyeles in pregnancy and lactation are limited. The product’s pregnancy category is listed as unknown, so it should only be used if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.
How do I order Menyeles from GNH USA?+
To request Menyeles, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Menyeles compare with using salbutamol alone?+
Menyeles combines salbutamol with ipratropium, offering both β2‑agonist and anticholinergic actions. Compared with salbutamol alone, the combination can provide greater bronchodilation, especially in COPD, and may reduce the frequency of rescue inhaler use. The dual formulation may also lower the dose needed for each component.
How should Menyeles be stored and handled?+
Menyeles should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and excessive heat. Keep the inhaler cap tightly closed when not in use and avoid exposure to direct sunlight.
How is Menyeles administered?+
Menyeles is delivered via a metered‑dose inhaler or nebulizer, as directed by the prescriber. The patient should inhale a measured puff or nebulized dose, hold their breath briefly, and repeat if multiple puffs are prescribed. Proper inhalation technique maximizes drug deposition in the lungs.
What are the most serious risks associated with Menyeles?+
Serious adverse events, although rare, include paradoxical bronchospasm, angioedema, and cardiac arrhythmias such as tachyarrhythmia. Patients should seek immediate medical attention if they experience worsening breathing, swelling of the face or throat, or irregular heartbeats after using the product.
Who should not use Menyeles?+
Menyeles is contraindicated in individuals with known hypersensitivity to salbutamol, ipratropium, or any excipients in the formulation. It should also be avoided in patients who have experienced a severe allergic reaction to similar bronchodilators or who have certain cardiac conditions where β2‑agonists are prohibited.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Salbutamol Sulfate, Ipratropium Bromide
Route
Inhalation Use
Manufacturer
Genetic Spa
Origin
EU

Related products

Almeida

Almeida

Salbutamol Sulfate, Ipratropium Bromide

I.B.N. Savio S.R.L.
EU
Berovent

Berovent

Salbutamol Sulfate, Ipratropium Bromide

Boehringer Ingelheim Hellas Single Member S.A.
EU
Biwind

Biwind

Salbutamol Sulfate, Ipratropium Bromide

Neopharmed Gentili Spa
EU
Butapral

Butapral

Salbutamol Sulfate, Ipratropium Bromide

Genetic Spa
EU